CYP1A1 and acute lymphoblastic leukemia: We found that both variant (CC) and heterozygous genotype (CT) of CYP1A1*2A polymorphism were associated with ALL risk, but this risk did not persist in the adjusted model (OR=6.76, P>0.100), when results were adjusted for potential confounders.